A New Emerging Threat in Critical Care: Myroides odoratimimus Outbreak in a Tertiary Hospital

ArticleAçık Erişim

Özet

Aims and background:Myroides spp. is an environmental pathogen and causes disease in immunocompromised patients. In this study, we report an outbreak of urinary tract infections (UTIs) caused by Myroides odoratimimus (M. odoratimimus) in a university hospital in Turkey. Methods: A total of 25 M. odoratimimus strains isolated from the clinical samples of 20 patients in our intensive care units and clinics were included in the study. Phenotypic and genotypic identification of isolates was performed using conventional methods, VITEK®-2 automated identification system, Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry, and 16S-RNA Microbial Diagnosis methods. In addition, the repetitive extragenic palindromic (REP) elements polymerase chain reaction (PCR) assay method was applied for molecular epidemiological analysis. Results: All cases were diagnosed with nosocomial UTI, except for one case diagnosed with nosocomial bacteremia. One of the M. odoratimimus isolates was sensitive to piperacillin/tazobactam (MIC: ≤4 µg/mL), and one isolate was moderately sensitive to cefepime (MIC: 16 µg/mL). Other all M. odoratimimus isolates were resistant to the tested antibiotics beta-lactams, monobactams, carbapenems, aminoglycosides, fluoroquinolones, and sulphonamides. When 10 isolates were evaluated with the REP PCR method, DNA fingerprint similarities were visually determined, and there was a similar DNA pattern among them. The source of Myroides infection could not be identified from the environmental samples. Conclusions: The increasing population of immunosuppressed patients suggests that M. odoratimimus and other opportunistic multi-drug resistant pathogens with resistance to broad-spectrum antibiotics may be encountered more frequently in critical units in future. In order to choose the optimal antibiotic regimen, awareness and an index of suspicion regarding this atypical pathogen are important for rapid identification and appropriate susceptibility testing. Clinical significance: It has been observed that the pathogenicity of M. odoratimimus bacteria has increased recently, and it can not only cause UTIs but more serious manifestations such as sepsis with bacteremia, which can be life-threatening. © The Author(s).

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10982Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorSavci, Unsal
dc.contributor.authorEser, Baris
dc.contributor.authorSungur, Mustafa
dc.contributor.authorYildiz, Serap S.
dc.contributor.authorAkdogan, Ozlem
dc.contributor.authorCaliskan, Selahattin
dc.contributor.authorSahin, Mustafa
dc.date.accessioned2026-10-18T20:26:05.549185631Z
dc.date.available2026-10-18T20:26:05.549185631Z
dc.date.issued2025
dc.description.abstractAims and background:Myroides spp. is an environmental pathogen and causes disease in immunocompromised patients. In this study, we report an outbreak of urinary tract infections (UTIs) caused by Myroides odoratimimus (M. odoratimimus) in a university hospital in Turkey. Methods: A total of 25 M. odoratimimus strains isolated from the clinical samples of 20 patients in our intensive care units and clinics were included in the study. Phenotypic and genotypic identification of isolates was performed using conventional methods, VITEK®-2 automated identification system, Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry, and 16S-RNA Microbial Diagnosis methods. In addition, the repetitive extragenic palindromic (REP) elements polymerase chain reaction (PCR) assay method was applied for molecular epidemiological analysis. Results: All cases were diagnosed with nosocomial UTI, except for one case diagnosed with nosocomial bacteremia. One of the M. odoratimimus isolates was sensitive to piperacillin/tazobactam (MIC: ≤4 µg/mL), and one isolate was moderately sensitive to cefepime (MIC: 16 µg/mL). Other all M. odoratimimus isolates were resistant to the tested antibiotics beta-lactams, monobactams, carbapenems, aminoglycosides, fluoroquinolones, and sulphonamides. When 10 isolates were evaluated with the REP PCR method, DNA fingerprint similarities were visually determined, and there was a similar DNA pattern among them. The source of Myroides infection could not be identified from the environmental samples. Conclusions: The increasing population of immunosuppressed patients suggests that M. odoratimimus and other opportunistic multi-drug resistant pathogens with resistance to broad-spectrum antibiotics may be encountered more frequently in critical units in future. In order to choose the optimal antibiotic regimen, awareness and an index of suspicion regarding this atypical pathogen are important for rapid identification and appropriate susceptibility testing. Clinical significance: It has been observed that the pathogenicity of M. odoratimimus bacteria has increased recently, and it can not only cause UTIs but more serious manifestations such as sepsis with bacteremia, which can be life-threatening. © The Author(s).
dc.identifier.doi10.5005/jp-journals-10071-25071
dc.identifier.eissn1998-359X
dc.identifier.endpage838
dc.identifier.issn0972-5229
dc.identifier.issue10
dc.identifier.pmcidPMC12592946
dc.identifier.pmid41210544
dc.identifier.scopus2-s2.0-105020808850
dc.identifier.startpage829
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10982
dc.identifier.volume29
dc.identifier.wosWOS:001599833200008
dc.language.isoen
dc.publisherJaypee Brothers Medical Publishers (P) Ltd
dc.relation.ispartofIndian Journal of Critical Care Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMultiple drug resistance
dc.subjectMyroides odoratimimus
dc.subjectMyroides spp
dc.subjectNosocomial infection
dc.subjectOutbreak in hospital
dc.subjectamikacin
dc.subjectaminoglycoside
dc.subjectantibiotic agent
dc.subjectaztreonam
dc.subjectcarbapenem derivative
dc.subjectcefepime
dc.subjectceftazidime
dc.subjectceftriaxone
dc.subjectcilastatin
dc.subjectcilastatin plus imipenem
dc.subjectciprofloxacin
dc.subjectcolistin
dc.subjectcorticosteroid
dc.subjectcotrimoxazole
dc.subjectertapenem
dc.subjectgentamicin
dc.subjectimipenem
dc.subjectlevofloxacin
dc.subjectlinezolid
dc.subjectmeropenem
dc.subjectmonobactam derivative
dc.subjectmoxifloxacin
dc.subjectnetilmicin
dc.subjectpiperacillin
dc.subjectpiperacillin plus tazobactam
dc.titleA New Emerging Threat in Critical Care: Myroides odoratimimus Outbreak in a Tertiary Hospital
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus3
rdl.citation.wos2
rdl.departmentDepartment of Urology, Erzincan Binali Yıldırım University, Faculty of Medicine, Erzincan, Türkiye.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)